Laura Gravelin is a Cardiology physician affiliated with Mount Carmel Health. OpenAlex indexes 12 publications with 403 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5300 N Meadows Dr
Grove City, OH 431232546
Telephone
614-627-2000Provider last certified this registry record 11 Apr 2022.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year202515 payments$13,725openpaymentsdata.cms.gov ↗
- Medtronic, Inc.Program year20256 payments
- Biosense Webster, Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
69.4%Beta blocker30.1%Metoprolol Succinate50%Carvedilol21%Metoprolol Tartrate13%Sotalol11%Atenolol4%Part D<11 patientsCalcium channel blocker8.5%Diltiazem 24hr Er (Cd)59%Amlodipine Besylate20%Nifedipine Er14%Diltiazem 24hr Er8%Part D<11 patients+ 11 more classes in this area
Blood & clotting
28.8%Factor Xa inhibitor25%Eliquis84%Xarelto17%Part D≥118 patientsP2Y12 inhibitor3.2%Clopidogrel100%Part D≥28 patients+ 1 more class in this area
Metabolism & gastrointestinal
1.8%Potassium supplement1%Potassium Chloride100%Part D<11 patientsSGLT2 inhibitor0.8%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- IMPLEMENTATION OF EHR-INTEGRATED NOTIFICATIONS ON PATIENTS AT RISK FOR SUDDEN CARDIAC ARREST
Journal of the American College of Cardiology
2025 - Personalized Intervention Strategy Based on a Risk Score Generated From Subcutaneous Insertable Cardiac Monitor: Results From Phase 1 of ALLEVIATE‐HF
Journal of the American Heart Association
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Mazen Awais
Mount Carmel Health
Asok Dasgupta, MD
Mount Carmel Health
Anantha Padmanabhan, MD
Mount Carmel Health
Abhay Gokhale, MD
Mount Carmel Health
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”